Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0CI9T
|
||||
Former ID |
DCL000744
|
||||
Drug Name |
Ceftobiprole
|
||||
Synonyms |
BAL 9141; BAL 9141-000; BAL-9141; Ro 63-9141; Ro-63-9141; Ro-63-9141/000; (6R,7R)-7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-ylidene)-2-nitrosoacetyl]amino]-8-oxo-3-[(E)-[2-oxo-1-[(3R)-pyrrolidin-3-yl]pyrrolidin-3-ylidene]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Intensive care unit; Bacterial infections [ICD9: 001-009, 001-139, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104; ICD10:A00-B99] | Phase 1 | [536773] | ||
Company |
Johnson & Johnson
|
||||
Structure |
Download2D MOL |
||||
Formula |
C20H22N8O6S2
|
||||
Canonical SMILES |
C1CNCC1N2CCC(=CC3=C(N4C(C(C4=O)NC(=O)C(=C5NSC(=N5)N)N=O<br />)SC3)C(=O)O)C2=O
|
||||
InChI |
1S/C20H22N8O6S2/c21-20-24-14(26-36-20)11(25-34)15(29)23-12-17(31)28-13(19(32)33)9(7-35-18(12)28)5-8-2-4-27(16(8)30)10-1-3-22-6-10/h5,10,12,18,22,26H,1-4,6-7H2,(H2,21,24)(H,23,29)(H,32,33)/b8-5+,14-11-/t10-,12-,18-/m1/s1
|
||||
InChIKey |
LXLDMYXULSBRCX-HZEONMFJSA-N
|
||||
CAS Number |
CAS 209467-52-7
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Bacterial penicillin binding protein | Target Info | Modulator | [552696] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.